MR Spectroscopy in brain tumors [MR-spektroskopie bei hirntumoren]

被引:0
|
作者
Papanagiotou P. [1 ,2 ]
Backens M. [1 ]
Grunwald I.Q. [1 ]
Farmakis G. [1 ]
Politi M. [1 ]
Roth C. [1 ]
Reith W. [1 ]
机构
[1] Klinik für Diagnostische und Interventionelle Neuroradiologie, Universitätsklinikum des Saarlandes, Homburg, Saar
[2] Klinik für Diagnostische und Interventionelle Neuroradiologie, Universitätsklinikum des Saarlandes, 66421 Homburg, Saar
来源
Der Radiologe | 2007年 / 47卷 / 6期
关键词
Intracerebral space-occupying lesions; Magnetic resonance spectroscopy (MRS); Metabolite constellations; Metabolites; Reference value;
D O I
10.1007/s00117-007-1522-8
中图分类号
学科分类号
摘要
MRT allows the anatomical visualization of intracerebral space-occupying lesions, and when magnetic resonance spectroscopy (MRS) is used in routine clinical practice it can give more information and be helpful in the diagnosis of such lesions. In MRS with long echo times for nerve tissue there are five metabolites that are particularly significant: N-acetyl aspartate (NAA), creatine, choline, lactate, and lipids. NAA levels are lowered in the presence of intracerebral tumors. Creatine is lowered in situations of hypermetabolic metabolism and elevated in hypometabolic conditions, but remains constant in many pathologic states and can be used as a reliable reference value. With malignant tumors there are usually elevated choline concentrations, reflecting increased membrane synthesis and a higher cell turnover. The lactate level rises following a switch in metabolism from aerobic to anaerobic glycolysis, and this is frequently observed in the presence of malignant tumors. The occurrence of lipid peaks in a tumor spectrum suggests the presence of tissue necroses or metastases. There are typical constellations that are seen on MRS for individual tumors, which are discussed in detail in the present paper. © 2007 Springer Medizin Verlag.
引用
收藏
页码:520 / 529
页数:9
相关论文
共 50 条
  • [41] COMPLEMENTARY ROLES OF PET AND MR SPECTROSCOPY IN THE MANAGEMENT OF BRAIN-TUMORS
    ALAVI, A
    ALAVI, JB
    LENKINSKI, RE
    RADIOLOGY, 1990, 177 (03) : 617 - 618
  • [42] PROTON MR SPECTROSCOPY OF EXPERIMENTAL BRAIN-TUMORS IN-VIVO
    GYNGELL, ML
    ELS, T
    HOEHNBERLAGE, M
    HOSSMANN, KA
    ACTA NEUROCHIRURGICA, 1994, : 350 - 352
  • [43] Brain MR imaging and proton MR spectroscopy in cognitive impairment
    Weiss, U
    Bacher, R
    Vonbank, H
    Kemmler, G
    Lingg, A
    Marksteiner, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S375 - S376
  • [44] MR Imaging of Pediatric Brain Tumors
    Jaju, Alok
    Yeom, Kristen W.
    Ryan, Maura E.
    DIAGNOSTICS, 2022, 12 (04)
  • [45] PET and MR Imaging of Brain Tumors
    Goldberg, Michael F.
    Chawla, Sanjeev
    Alavi, Abass
    Torigian, Drew A.
    Melhem, Elias R.
    PET CLINICS, 2008, 3 (03) : 293 - +
  • [46] 1H-MR-Spektroskopie des zervikalen Myelons bei Patienten mit MS
    C. Lukas
    B. Bellenberg
    M. Busch
    C. Tönnes
    R. Gold
    A. Chan
    Der Nervenarzt, 2010, 81 : 14 - 15
  • [47] REVIEW: MR elastography of brain tumors
    Bunevicius, Adomas
    Schregel, Katharina
    Sinkus, Ralph
    Golby, Alexandra
    Patz, Samuel
    NEUROIMAGE-CLINICAL, 2020, 25
  • [48] In vivo proton MR spectroscopy of myoinositol and choline levels in brain tumors of childhood
    Wang, ZJ
    Sutton, L
    Haselgrove, JC
    Rorke, LB
    Hunter, JV
    Zimmerman, RA
    RADIOLOGY, 1996, 201 : 967 - 967
  • [49] Residual or recurrent brain tumors: Evaluation with proton MR spectroscopy and thallium SPECT
    Thompson, JE
    Mukherji, SK
    Kwock, L
    Smith, MM
    Castillo, M
    Bujenovic, S
    RADIOLOGY, 1996, 201 : 143 - 143
  • [50] Brain tumors: Localized H-1 MR spectroscopy at 0.5 T
    Prost, R
    Haughton, V
    Li, SJ
    RADIOLOGY, 1997, 204 (01) : 235 - 238